1-20 of 54
Jie Xu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Chronic eosinophilic leukemia with a novel JAK1 mutation responds well to the JAK1/2 inhibitor ruxolitinib

Qing Wei, Jie Xu
Journal: Blood
Blood (2024) 144 (2): 238.
https://doi.org/10.1182/blood.2024024626
Published: 2024
Journal Articles

Prognostic Significance of CD30 Expression and Response to Brentuximab Vedotin in Patients with Angioimmunoblastic T Cell Lymphoma

Alexandra Elias, Mario L. Marques-Piubelli, Ranjit Nair, Rishab Prakash, Sairah Ahmed, Luis Malpica, Hun Ju Lee, Jie Xu, Christopher R. Flowers, Sattva S. Neelapu, Francisco Vega, Roberto Miranda, Swami P. Iyer
Journal: Blood
Blood (2023) 142 (Supplement 1): 1714.
https://doi.org/10.1182/blood-2023-187939
Published: 2023
Journal Articles

Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Gastric MALT Lymphoma

Jillian Gunther, Jie Xu, Manoop S Bhutani, Paolo Strati, Penny Fang, Susan Wu, Bouthaina S. Dabaja, Wenli Dong, Priya Bhosale, Christopher R. Flowers, Ranjit Nair, Luis Malpica, Preetesh Jain, Sattva S. Neelapu, Maria Alma Rodriguez, Dai Chihara, Loretta J. Nastoupil, Chelsea Camille Pinnix
Journal: Blood
Blood (2023) 142 (Supplement 1): 298.
https://doi.org/10.1182/blood-2023-181757
Published: 2023
Journal Articles

The Promising Third-Generation TKI Olverembatinib in Adult BCR::ABL1-Positive Acute Lymphoblastic Leukemia with T315I Mutation and Relapsed/Refractory Disease

Weiyang Liu, Cheng Wang, Sijie Tang, Jiayi Ren, Lijun Peng, Yongmei Zhu, Xiangqin Weng, Wanyan Ouyang, Jie Xu, Yuanfang Liu, Weiping Zhang, Jin Wang, Jian-Qing Mi
Journal: Blood
Blood (2023) 142 (Supplement 1): 5902.
https://doi.org/10.1182/blood-2023-188733
Published: 2023
Journal Articles

Real-World Outcomes of Zanubrutinib Monotherapy in Chronic Lymphocytic Leukemia: A Multicenter Retrospective Study

Jing Luo, Jiaojiao Zhang, Ligen Liu, Rong Wei, Yonghua Yao, Min Xu, Jie Xu, Jumei Shi, Jianmin Yang, Jian Hou, Jin Wang, Jian-Qing Mi
Journal: Blood
Blood (2023) 142 (Supplement 1): 6540.
https://doi.org/10.1182/blood-2023-180477
Published: 2023
Journal Articles

Unraveling the Transcriptional Landscape of Nodular Lymphocyte-Predominant Hodgkin Lymphoma and T-Cell/Histiocyte Rich Large B-Cell Lymphoma: Impact of Tumor Microenvironment and Checkpoint Gene Expression

Ilja Kalashnikov, Veronica Russell, Panu Kovanen, Johannes Dunkel, Marja-Liisa Karjalainen-Lindsberg, Annika Pasanen, Rachel Kositsky, Sarah L. Ondrejka, Tanu Goyal, Eric D. Hsi, Mette Ølgod Pedersen, Anne Ortved Gang, Magdalena Czader, Jiehao Zhou, Mina Xu, Nathan Paulson, Jean L. Koff, Andrew G Evans, Yasodha Natkunam, Ridas Juskevicius, Abner Louissaint, Elizabeth Thacker, Tushar Dave, Cassandra L. Love, Chad M McCall, Choon Kiat Ong, Michael Churnetski, Haley Martin, Jennifer R. Chapman-Fredricks, Javeed Iqbal, Amy Chadburn, Payal Sojitra, Amir Behdad, William Choi, Jie Xu, Emily F. Ferguson Mason, Kikkeri N Naresh, Yuri D. Fedoriw, Dina Sameh Soliman, Sandeep Dave, Sirpa Leppä
Journal: Blood
Blood (2023) 142 (Supplement 1): 176.
https://doi.org/10.1182/blood-2023-182294
Published: 2023
Journal Articles

Metabolomic Insights into the Pathogenesis and Prognostic Potential of Adult Acute Lymphoblastic Leukemia

Junyu Wang, Tuantuan Gui, Tong Yin, Yuting Dai, Jing Qiao, Jianfeng Li, Jie Xu, Yuanfang Liu, Yan Wang, Yun Tan, Bo Jiao, Yongmei Zhu, Zhu Chen, Wenlian Chen, Hai Fang, Jian Hou, Jian-Qing Mi, Jin Wang, Sai-Juan Chen
Journal: Blood
Blood (2023) 142 (Supplement 1): 2971.
https://doi.org/10.1182/blood-2023-184328
Published: 2023
Journal Articles

Developing Deep Learning Pipeline of Whole-Slide Images for Enhanced Diffuse Large B Cell Lymphoma (DLBCL) Subtyping and Outcome Prediction: Leveraging Self-Attention Transformer for Training and Inference

Chen Zhou, Jie Xu, Rishab Prakash, Carlos P Torres-Cabala, Cheng-bang Chen, Kamesh Madduri, Arvind Rao, Greeshma Agasthya, Francisco Vega, Dennis O'Malley, L. Jeffrey Medeiros, Soundar Kumara, Swami P. Iyer
Journal: Blood
Blood (2023) 142 (Supplement 1): 904.
https://doi.org/10.1182/blood-2023-187291
Published: 2023
Journal Articles

Optical Genomic Mapping Provides Unique Findings in Various Types of Myeloid Neoplasms

Andres E Quesada, Gokce A. Toruner, Zhenya Tang, Shimin Hu, Jie Xu, Shaoying Li, Farhad Ravandi, Hagop M. Kantarjian, M. James You, L. Jeffrey Medeiros, Guilin Tang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4303.
https://doi.org/10.1182/blood-2023-177803
Published: 2023
Journal Articles

SUMO E3 Ligase ZMIZ1 Drives Leukemogenesis Via Transcriptional Deregulation in Acute Myeloid Leukemia

Fu Ziyu, Yun Tan, Xiaoguang Xu, Jie Xu, Sai-Juan Chen
Journal: Blood
Blood (2023) 142 (Supplement 1): 4134.
https://doi.org/10.1182/blood-2023-187978
Published: 2023
Journal Articles

A Phase II Study of Flumatinib with Chemotherapy for Newly Diagnosed BCR::ABL1-Positive Acute Lymphoblastic Leukemia in Adults: Updated Results from RJ-ALL2020.2A Trial

Weiyang Liu, Cheng Wang, Sijie Tang, Jiayi Ren, Lijun Peng, Yongmei Zhu, Xiangqin Weng, Wanyan Ouyang, Jie Xu, Yuanfang Liu, Weiping Zhang, Jian-Qing Mi, Jin Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5880.
https://doi.org/10.1182/blood-2023-180326
Published: 2023
Journal Articles

Dose Escalation of Blinatumomab Is a Better Option for MRD-Positive CR Patients, Results from a Single-Center Real World Study of Blinatumomab for B-Cell Acute Lymphoblastic Leukemia in China

Sijie Tang, Jiayi Ren, Weiyang Liu, Xiangqin Weng, Yongmei Zhu, Cheng Wang, Lijun Peng, Wenqian Xu, Yuxuan Shang, Wenyan Yu, Jiaojiao Zhang, Jie Xu, Yuanfang Liu, Weiping Zhang, Jian-Qing Mi, Jin Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5885.
https://doi.org/10.1182/blood-2023-189703
Published: 2023
Journal Articles

Outcomes in Patients with Relapsed Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Treated with CAR-T Cell Therapies or Salvage Chemotherapy - a Single-Institution Experience

Ranjit Nair, Iyanuoluwa Ogundipe, Jillian Gunther, L. Jeffrey Medeiros, Preetesh Jain, Loretta J. Nastoupil, Chelsea Camille Pinnix, Luis Malpica, Sairah Ahmed, Roberto Miranda, Luis Fayad, Raphael E Steiner, Frederick Hagemeister, Hun Ju Lee, Maria Alma Rodriguez, Paolo Strati, Dai Chihara, Michael Wang, Yago Nieto, Jeremy Ramdial, Ajlan Al Zaki, Chijioke Nze, Michael R. Green, Bouthaina S. Dabaja, Jie Xu, Beenu Thakral, Sattva S. Neelapu, Francisco Vega, Christopher R. Flowers, Penny Fang, Jason Westin, Lei Feng, Swami P. Iyer
Journal: Blood
Blood (2023) 142 (Supplement 1): 6327.
https://doi.org/10.1182/blood-2023-191096
Published: 2023
Journal Articles

Clinical Characteristics and Survival Analysis of Richter Transformation: A Single Center Retrospective Study in China

Jiaojiao Zhang, Jing Luo, Lei Dong, Xiangqin Weng, Jie Xu, Jin Wang, Jian-Qing Mi
Journal: Blood
Blood (2023) 142 (Supplement 1): 6384.
https://doi.org/10.1182/blood-2023-187133
Published: 2023
Journal Articles

The Prognostic Significance of 1-Year Persistent MRD Negativity in Chinese ALL Patients: 5-Year Follow-up Results from RJ-ALL 2014 Trial

Jiayi Ren, Sijie Tang, Weiyang Liu, Xiangqin Weng, Cheng Wang, Lijun Peng, Wenqian Xu, Yuxuan Shang, Jie Hao, Wenyan Yu, Jiaojiao Zhang, Jie Xu, Yuanfang Liu, Weiping Zhang, Jin Wang, Jian-Qing Mi
Journal: Blood
Blood (2023) 142 (Supplement 1): 6057.
https://doi.org/10.1182/blood-2023-189710
Published: 2023
Journal Articles

Mutations of ATM Confer a Risk of Inferior Survival in Patients with TP53- wild Type Mantle Cell Lymphoma

Jean L. Koff, Rachel Kositsky, David L Jaye, Michael C. Churnetski, Katelin Baird, Colin B. O'Leary, Christopher R. Flowers, Sirpa Leppa, Marja-Liisa Karjalainen-Lindsberg, Shaoying Li, Jie Xu, Mette Ø Pedersen, Anne Ortved Gang, Kikkeri N Naresh, Rebecca J Leeman-Neill, Kwok Him Rex Au Yeung, Hina Naushad Qureishi, Javeed Iqbal, Jennifer R Chapman-Fredricks, Chad M. McCall, Michael Crump, Amy Chadburn, Erin C. Mulvey, Izidore S. Lossos, Sandra L. Ondrejka, Eric D. Hsi, Abner Louissaint, Jr., Haley Martin, Eric Tse, Cassandra Love, Tushar Dave, Clay Parker, Choon Kiat Ong, Andrew G Evans, Amir Behdad, Lixin Yang, Nishitha Reddy, Mary Ann Arildsen, Ridas Juskevicius, Jiong Yan, Magdalena Czader, Andrew M. Evens, Dina Sameh Soliman, Yuri Fedoriw, Sandeep S. Dave, Jonathon B. Cohen
Journal: Blood
Blood (2022) 140 (Supplement 1): 3500–3503.
https://doi.org/10.1182/blood-2022-168002
Published: 2022
Journal Articles

Cutaneous/ Subcutaneous Involvement - an Immune privileged Site Associated with Poor Outcomes in Systemic Peripheral T/ NK Cell Lymphoma.

Ranjit Nair, Rishab Prakash, Anna Dang, Jillian R. Gunther, Auris Huen, Jie Xu, Luis Enrique Malpica Castillo, Carlos Torres Cabala, Meghan Heberton, Penny Fang, Sairah Ahmed, Roberto N. Miranda, Luis Fayad, Raphael Steiner, Hun Ju Lee, Dai Chihara, Preetesh Jain, Samer A Srour, Jeremy L Ramdial, Yago Nieto, Loretta J. Nastoupil, Chelsea C. Pinnix, Sattva S. Neelapu, Christopher R. Flowers, L. Jeffrey Medeiros, Chitra Hosing, Michael L. Wang, Bouthaina S. Dabaja, Francisco Vega, Lei Feng, Swaminathan Padmanabhan Iyer
Journal: Blood
Blood (2022) 140 (Supplement 1): 12005–12007.
https://doi.org/10.1182/blood-2022-170750
Published: 2022
Journal Articles

Functional Disruption of TET2-Mediated Cytosine Oxidation in CAR-T Cells Using IDH1 Neomorph

Kunho Chung, Jie Xu, Yaroslav Kaminskiy, Hongxing Sun, Min-Soo Kim, Christopher Petucci, Tong Wang, Rahul M Kohli, J. Joseph Melenhorst
Journal: Blood
Blood (2022) 140 (Supplement 1): 628–629.
https://doi.org/10.1182/blood-2022-159517
Published: 2022
Journal Articles

Clinical Outcomes of Patients with Breast Implant- Associated Anaplastic Large- Cell Lymphoma (BIA-ALCL) Treated with Chemotherapy and Brentuximab Vedotin

Alexandra Elias, Rishab Prakash, Loretta J. Nastoupil, Nathan H. Fowler, Sairah Ahmed, Ranjit Nair, Luis Enrique Malpica Castillo, Bouthaina S. Dabaja, Jie Xu, Jeffrey Medeiros, John Stewart, Wei Wang, Chelsea C. Pinnix, Kelly Hunt, Mark W Clemens, Roberto N. Miranda, Swaminathan P. Iyer
Journal: Blood
Blood (2022) 140 (Supplement 1): 3721–3723.
https://doi.org/10.1182/blood-2022-170845
Published: 2022
Journal Articles

The First Report of Third-Generation TKI Olverembatinib in Adult Ph/BCR-ABL1-Positive Acute Lymphoblastic Leukemia with T315I Mutation and Relapsed Disease

Weiyang Liu, Yuanfang Liu, Yongmei Zhu, Xiangqin Weng, Cheng Wang, Wanyan Ouyang, Jie Xu, Jin Wang, Jian-Qing Mi
Journal: Blood
Blood (2022) 140 (Supplement 1): 3266–3267.
https://doi.org/10.1182/blood-2022-166482
Published: 2022